Reply

Affiliations

¹ Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts.

Comment

Tracey G Simon et al. Clin Gastroenterol Hepatol. 2020 Feb.

. 2020 Feb;18(2):523-524.

doi: 10.1016/j.cgh.2019.07.041. Epub 2019 Jul 25.

¹ Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts.

No abstract available

Comment on

Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG, Henson J, Osganian S, Masia R, Chan AT, Chung RT, Corey KE. Simon TG, et al. Clin Gastroenterol Hepatol. 2019 Dec;17(13):2776-2784.e4. doi: 10.1016/j.cgh.2019.04.061. Epub 2019 May 9. Clin Gastroenterol Hepatol. 2019. PMID: 31077838 Free PMC article.
Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease.
Severo MD. Severo MD. Clin Gastroenterol Hepatol. 2020 Feb;18(2):523. doi: 10.1016/j.cgh.2019.05.034. Clin Gastroenterol Hepatol. 2020. PMID: 31937400 No abstract available.